+48%, +39%, +22%: Our AI just called these blue-chip breakouts

Wednesday night, Meta buried a number in its Q3 release that reframes the entire blue-chip landscape: $135–145 billion of additional AI infrastructure spending. Not cumulative. Additional. It came alongside record revenue of $64.6 billion (+26% y/y), EPS of $3.83 against a $3.45 estimate, and a 2-for-1 stock split - and Tesla, IBM and Texas Instruments all beat on the same night. The Dow closed at 52,856.09 (+0.69%), the S&P 500 at 7,757.17 (+0.58%), the Nasdaq at 26,702.86 (+1.05%).

Here is the uncomfortable part for most investors: that spending has to land on somebody’s income statement, and by the time a capex number that large is public, the stocks positioned to receive it have already moved. Investing.com’s AI-powered strategies bought them months ago.

See every stock the AI is holding right now on ProPicks AI

The model doing the picking

Dominate the Dow describes its own mandate plainly: “Our AI analyzes all 30 blue chip stocks to pinpoint the 10 strongest stocks each month for market-beating returns.” The screen runs monthly on three things - momentum, valuation, and underlying business performance - and rebalances without sentiment.

The scoreboard: +20.82% in 2026, ahead of the Dow by 10.93 percentage points, and +5.58% this month versus the index’s +3.79%. Nine of ten holdings are green on the month.

What follows is not a victory lap. It is what the model actually saw.

Salesforce (NYSE:CRM) - +48.4% since entry

The model bought on July 1 at $162.94. Wednesday’s close: $241.78.

This is the clearest window into how the engine thinks, because buying Salesforce in July required ignoring the tape. The stock had de-rated savagely - it was still down 11.41% for 2026 as recently as the October 2 close, against a 52-week high of $267.75. Sentiment was gone.

What the model would have scored instead: Salesforce was compounding through the drawdown. Agentforce and Data 360 combined ARR reached nearly $3.9 billion, up over 210% year-over-year, with Agentforce alone crossing $1.5 billion. Q2 FY27 revenue was $11.345 billion (+10.8%), FY27 guidance was lifted to $46.1–46.4 billion, and non-GAAP operating margin guidance sits at 34.3%. A $25 billion accelerated repurchase cut the diluted share count to 821 million from 962 million - a 14.7% reduction in a single year, which flatters every per-share figure going forward. Free cash flow grew 81.5%.

And the valuation was the kicker: at roughly 14.5x forward earnings against FY27 EPS guidance of $16.67–16.71, this was AI-agent exposure priced like a utility while Nasdaq peers traded at three times the multiple.

The honest caveat: Q2’s headline EPS was inflated. GAAP EPS of $4.29 and non-GAAP of $5.90 included gains of $2.43 and $2.53 per share from strategic investments - largely Anthropic. Strip those out and operating income was roughly flat year-over-year. The Informatica integration is a live execution risk. Of 55 analysts, 40 are positive, 13 hold, 2 strongly negative.

Microsoft (NASDAQ:MSFT) - +39.0% since entry

Bought July 1 at $383.56. Wednesday’s close: $532.95.

Microsoft is the most direct beneficiary of the number Meta just printed, and the proof arrives in six days: Q1 FY27 lands Wednesday, October 28 after the close, with the call at 2:30 p.m. Pacific - confirmed by Microsoft’s own investor relations.

The setup is specific. Intelligent Cloud is guided to $40.95–41.25 billion, Productivity & Business Processes to $36.7–37.0 billion. Azure is expected to grow roughly 45% in constant currency, accelerating from 43% in Q4 FY26 - Bernstein, which reiterated Outperform on October 19 and nudged its target to $662 from $660, models 45.6% against 44.9% consensus, with M365 Commercial Cloud at 18%. Quarterly capex is expected to top $50 billion.

The number most investors miss: paid Microsoft 365 Copilot seats passed 30 million in Q4 FY26, up from 20 million the prior quarter - a 50% sequential step-up. That is monetisation arriving, not promised. Commercial bookings carry a 2.3-year weighted average duration, and the portion of backlog recognisable beyond twelve months grew 112%.

The honest caveat: this is the most expensive AI bet in the index. Cloud gross margin has compressed from 72% three years ago toward the mid-60s as AI infrastructure costs land. If Azure prints 43% instead of 45% on the 28th, the capex question gets loud fast.

Apple (NASDAQ:AAPL) - +21.8% since entry

Held since December 1, 2025 at $282.33. Wednesday: a new all-time closing high of $343.99, up $4.49 on the session, lifting market cap to $5.020 trillion - second only to NVIDIA.

This is the position where the model is most clearly out of consensus, and readers deserve that stated plainly. The Street’s average target is roughly $329 - below the current price. Loop Capital cut to Hold on October 20, moving its target from $370 to $330, citing Apple’s decision to trim planned September- and December-quarter iPhone shipments by 10%. Nikkei Asia reported October component orders for the iPhone 18 Pro and Pro Max cut by at least 15%. Morgan Stanley, which stayed Overweight at $355 on October 21, still called the setup “slightly challenging” and expects December-quarter iPhone revenue and gross margins to land slightly below Street.

What keeps the model long: IDC puts Q3 iPhone shipments down just 4% in a market that contracted 22% - the smallest decline among the top five vendors, meaning Apple is taking share while the category shrinks. June-quarter iPhone revenue grew 22%. And there is an unmodelled option: Apple’s own support documentation confirms expanded Siri AI access “will be available for a fee,” tied to the 2027 software releases. No price has been announced, so no analyst can put it in a model yet.

The test is November 2. The Street wants December-quarter guidance near $154 billion, about 7% growth.

Don’t guess which blue chip is next - let the AI screen all 30 for you

The rest of the book

Nine of ten holdings are green this month. UnitedHealth leads at +14.17%, then IBM +11.47%, Amgen +7.63%, McDonald’s +6.22%, Amazon +5.70%, Merck +4.22%, Apple +4.14%, Microsoft +3.93%, Salesforce +2.15%. Verizon is the only decliner at -3.79%.

Measured from entry, the gains run deeper still: Amgen is up 63.3% from its December 2024 entry at $268.46, and Merck 45.3% from $103.13 in January.

Where else the AI is beating its benchmark

The same two threads - AI infrastructure buildout and defensive quality at a discount - are producing alpha across the US book. Energy Elite leads everything at +77.27% for 2026, a full 30.33 points clear of its benchmark. Mid-Cap Movers is +42.48% (+32.03 vs benchmark), Small-Cap Sprinters +31.64% (+19.43), Healthcare Heroes +23.73% (+6.96), alongside Dominate the Dow’s own 10.93-point edge.

Five strategies. Five benchmarks beaten. One subscription.

Still not a member? Then here’s your chance to get the full list NOW:

How Investing.com’s AI-Powered Stock Picker Works

At the beginning of each month, our proprietary AI system evaluates thousands of global equities using a complex blend of historical data, valuation signals, and forward-looking growth metrics.

By processing more than 15 years of financial data across more than 150 quantitative models, the engine identifies up to 20 high-conviction stocks per strategy based on their projected medium-term upside potential.

Every month, these strategies undergo a strict rebalancing process. New opportunities are added, strong performers are retained, and stocks that no longer meet the criteria are removed.

To consistently track performance, each strategy utilises equal weighting across all selected stocks. While investors are free to adjust their own allocations, this structure provides a transparent benchmark for evaluating overall model performance.

The goal is to keep capital positioned in the companies showing the strongest combination of momentum, valuation, and business performance.

*Live performance is recorded since our official launch of the Beat the S&P 500 strategy in October 2023.

Subscription prices mentioned in articles are accurate at the time of publication. We regularly test different offers for our members, which may vary by region.

Past performance does not guarantee future results. Prices are accurate at the time of publication and may vary by region.

Data as of: October 22, 2026, 00:56 UTC.